We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Blood-Based Biomarker Assessed for Subtle Brain Injury

By LabMedica International staff writers
Posted on 10 May 2018
Print article
Image: The Simoa 2.0, ultrasensitive immunoassay platform used for measuring plasma tau and serum NfL (Photo courtesy of Quanterix).
Image: The Simoa 2.0, ultrasensitive immunoassay platform used for measuring plasma tau and serum NfL (Photo courtesy of Quanterix).
A high-sensitive blood test can aid concussed hockey players when it might be safe to return to play. The test has identified a superior blood-based biomarker for assessing subtle brain injury.

A study has compared neurofilament light (NfL) and tau as blood-based biomarkers for acute sports-related concussion (SRC) and determined whether their concentrations at different time points after the injury are associated with prolonged time to return to play (RTP).

Neuroscientists at the Sahlgrenska Academy (Gothenburg, Sweden) studied a total, 288 hockey players, which 105 suffered a concussion during three seasons from 2012 to 2015. From 87 of these players, blood samples were taken 1, 12, 36 and 144 hours (six days) after the concussion. A fifth sample was taken at the time when the person was determined fit to return to unrestricted competition.

Plasma tau and serum NfL were measured with a commercially available immunoassays using digital array technology. Samples for S100 calcium binding protein B (S100B) and neuron-specific enolase (NSE) were analyzed on a Modular E170 instrument. The limit of detection for the NfL assay is 0.29 pg/mL, which is approximately 100-fold more sensitive than conventional assay for the protein, while the limit of detection for tau is 0.02 pg/mL, which is over 1,000-fold more sensitive than conventional immunoassays for the protein.

The results show that it was the levels of the protein neurofilament light (NfL) that had the clearest connection to the severity of concussion, measured as the number of days it took for players to return to play. The levels of the other biomarkers that were studied (tau, S100B and, NSE) decreased quickly and could thereby not indicate how injured the players were after 7 to10 days, a time point many players returned to play in the study.

The authors concluded that serum NfL outperformed tau, S100B, and NSE as a biomarker for SRC. From a clinical standpoint, serum NfL may be useful to identify individuals at risk of prolonged PCS, and may aid in biomarker-informed decisions with regard to when RTP should be considered. Pashtun Shahim, MD, PhD, the lead author of the study, said, “The strength of this study is that we longitudinally followed how these biomarkers are released and cleared from the blood. What we observed was that NfL was released within an hour after the concussion, and then it increased over time in players who had prolonged symptoms.” The study was published on April 13, 2018, in the journal Neurology.

Related Links:
Sahlgrenska Academy

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.